FVIII inhibitor surveillance in children with hemophilia A in Indonesia: a report from the Indonesian Pediatric Hematology-Oncology Working Group

BACKGROUND: Factor VIII (FVIII) inhibitor diagnosis and surveillance in Indonesia are challenging owing to geographic conditions and the lack of laboratory facilities nationwide for inhibitor assays. This study aimed to determine the prevalence of FVIII inhibitors in children diagnosed with hemophil...

Descripción completa

Detalles Bibliográficos
Autores principales: Chozie, Novie Amelia, Gatot, Djajadiman, Sudarmanto, Bambang, Susanah, Susi, Purnamasari, Rini, Widjajanto, Pudjo Hagung, Nugroho, Susanto, Rasiyanti, Olga, Puspitasari, Dian, Riza, Muhammad, Larasati, Maria Christina Shanty, Adiyanti, Sri Suryo, Saraswati, Made Citra, Primacakti, Fitri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812731/
https://www.ncbi.nlm.nih.gov/pubmed/36535639
http://dx.doi.org/10.5045/br.2022.2022153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812731/
https://www.ncbi.nlm.nih.gov/pubmed/36535639
http://dx.doi.org/10.5045/br.2022.2022153

Ejemplares similares